Press release
Nucleic Acid Therapeutics Market Size Will Expected to Reach USD 17.7 Billion by 2034 | TMR Research
Nucleic acid therapeutics represent a transformative class of medical treatments that leverage the biological functions of nucleic acids-DNA, RNA, and their derivatives-to treat diseases at the molecular level. These therapies include gene therapies, RNA interference (RNAi), antisense oligonucleotides (ASOs), and mRNA vaccines. They offer the potential for highly targeted and personalized treatment approaches for a range of conditions, including genetic disorders, cancers, and infectious diseases. The global nucleic acid therapeutics market is expanding rapidly due to advances in biotechnology, increasing investment in research and development, and the success of recent clinical applications.Nucleic Acid Therapeutics Market (핵산 치료제 시장) is expected to grow at a CAGR of 12.6% from 2024 to 2034 and reach US$ 17.7 Bn by the end of 2034
Download Sample of the Report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86333
Overview of Nucleic Acid Therapeutics Market
The global nucleic acid therapeutics market is experiencing robust growth, driven by technological advancements, successful clinical outcomes, and rising demand for novel treatment options. The market is segmented by product type (gene therapies, RNA therapies, antisense oligonucleotides, aptamers, and mRNA therapies), application (genetic disorders, cancer, infectious diseases, and others), end-users (hospitals, academic and research institutes, biotechnology and pharmaceutical companies), and geographical regions.
Top Companies:
Silence Therapeutics
Ionis Pharmaceuticals, Inc.
Novartis AG
Arrowhead Pharmaceuticals
Stoke Therapeutics, Inc.
Moderna, Inc.
Alnylam Pharmaceuticals, Inc.
Biogen Inc.
Wave Life Sciences
Sarepta Therapeutics, Inc.
Recent Developments in Nucleic Acid Therapeutics Market
Recent advancements and trends in the nucleic acid therapeutics market include:
mRNA Vaccines: The success of mRNA vaccines, particularly during the COVID-19 pandemic, has accelerated interest and investment in nucleic acid-based vaccines for other infectious diseases and cancers.
CRISPR and Gene Editing: Advances in CRISPR-Cas9 and other gene-editing technologies are enabling precise modifications of genetic material, offering potential cures for genetic disorders and cancers.
RNA Interference (RNAi): Progress in RNAi technologies has led to the development of effective therapies for conditions such as hereditary transthyretin amyloidosis and acute hepatic porphyria.
Antisense Oligonucleotides (ASOs): ASOs are being increasingly used to modulate gene expression, with successful therapies for spinal muscular atrophy (SMA) and Duchenne muscular dystrophy (DMD).
Nanoparticle Delivery Systems: Advances in nanoparticle-based delivery systems are improving the stability, targeting, and efficacy of nucleic acid therapeutics.
Drivers of Market Growth
Several factors contribute to the growth of the nucleic acid therapeutics market:
Technological Advancements: Continuous innovations in nucleic acid synthesis, gene editing, and delivery technologies are driving market growth.
Successful Clinical Applications: Recent successful clinical applications and FDA approvals of nucleic acid therapeutics are boosting market confidence and investment.
Personalized Medicine: The growing emphasis on personalized medicine is driving the demand for nucleic acid therapeutics, which can be tailored to individual genetic profiles.
Rising Incidence of Genetic Disorders and Cancers: Increasing prevalence of genetic disorders and cancers is necessitating the development of novel and effective treatment options.
Investment in Research and Development: Significant investments by pharmaceutical and biotechnology companies in R&D are propelling the advancement and commercialization of nucleic acid therapeutics.
Explore Sample of the Report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86333
Conclusion
The nucleic acid therapeutics market is poised for significant growth, driven by technological advancements, successful clinical applications, and increasing demand for personalized medicine. Innovations in mRNA vaccines, gene editing, RNA interference, antisense oligonucleotides, and nanoparticle delivery systems are enhancing the efficacy and applicability of nucleic acid therapies.
Market Segmentation:
Product Type
RNA interference (RNAi) and Short Interfering RNAs
Antisense Oligonucleotides (ASOs)
Others
Application
Autoimmune Disorders
Infectious Diseases
Genetic Disorders
Cancer
Others
End-user
Hospitals
Specialty Clinics
Others (Research Organizations, etc.)
By Region
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
Buy this Premium Research Report:
https://www.transparencymarketresearch.com/checkout.php?rep_id=86333<ype=S
More Trending Report by Transparency Market Research:
Pharmaceutical Chemicals Market (医薬品化学品市場): https://www.globenewswire.com/en/news-release/2024/01/15/2808957/32656/en/Pharmaceutical-Chemicals-Market-Size-to-be-Worth-USD-339-3-billion-by-2031-with-a-Projected-CAGR-of-5-8-Says-Transparency-Market-Research-Inc.html
OPGW Cable Market (Marché des câbles OPGW): https://www.globenewswire.com/news-release/2024/02/28/2837197/32656/en/OPGW-Cable-Market-Expected-to-Reach-USD-876-8-million-by-2031-Growing-at-a-CAGR-of-4-8-Transparency-Market-Research-Inc.html
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Nucleic Acid Therapeutics Market Size Will Expected to Reach USD 17.7 Billion by 2034 | TMR Research here
News-ID: 3584077 • Views: …
More Releases from Transparency Market Research
Gas Compressor Market Outlook 2036: Global Industry Expected to Reach US$ 41.0 B …
The global gas compressor market was valued at US$ 23.2 Bn in 2025 and is projected to reach US$ 41.0 Bn by 2036, expanding at a compound annual growth rate (CAGR) of 5.3% from 2026 to 2036. This steady growth trajectory reflects the structural importance of gas compression systems across upstream, midstream, and downstream gas value chains. Rising natural gas consumption, expansion of pipeline and LNG infrastructure, and national energy…
Anesthesia Drugs Market to be Worth USD 12.6 Bn by 2036 - By Drug / By Applicati …
The global anesthesia drugs market was valued at US$ 7.6 billion in 2025 and is projected to reach US$ 12.6 billion by 2036, expanding at a compound annual growth rate (CAGR) of 4.7% from 2026 to 2036. This steady growth trajectory reflects the essential and non-substitutable role of anesthesia drugs in modern healthcare systems. As surgical interventions continue to rise globally-across both elective and emergency procedures-the demand for safe, effective,…
Single-Atom Catalysts Market Size is Expected to Expand from US$ 177.8 Million t …
The global single-atom catalysts (SACs) market is poised for remarkable growth as industries seek highly efficient, cost-effective, and sustainable catalytic solutions. Valued at US$ 177.8 million in 2025, the market is projected to reach US$ 1,000.2 million by 2036, expanding at a robust compound annual growth rate (CAGR) of 17.0% from 2026 to 2036. This rapid expansion reflects the growing importance of advanced catalysis in energy, chemicals, environmental protection, and…
Non-specific Endonuclease Market to Reach USD 726.6 Million by 2036, Supported b …
The non-specific endonuclease market is witnessing steady growth, driven by the expanding use of molecular biology tools across biotechnology, pharmaceuticals, diagnostics, and academic research. Non-specific endonucleases are enzymes that cleave nucleic acids without requiring a specific recognition sequence, making them highly valuable for applications such as DNA/RNA degradation, sample preparation, viscosity reduction, and contamination control. Their broad activity profile differentiates them from restriction enzymes and enables versatile usage across multiple…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
